The extreme discount to market and small cash balance suggest urgent financing needs. Expect near-term downward pressure as the discounted shares hit the market. The 90-day lock-up on insiders limits immediate selling, but the free-trading shares from the offering will likely overhang the stock. Monitor for further capital raises given the minimal cushion — China Pharma has now done two 424B5 offerings in ~7 months.
Price Chart
Executive Summary
China Pharma Holdings is conducting a deeply dilutive offering of 2.5M shares at $2.00/share — a 75% discount to the $8.10 prior close — raising ~$4.4M net for working capital. The company had only $168K cash as of March 31, 2026 and a negative tangible book value of ($1,620,880). The offering increases share count by 6.2% and signals acute capital needs given the extreme discount, likely pressuring the stock.
Key Facts
- 2,500,000 shares offered at $2.00 per share vs $8.10 prior close (75% discount)
- Net proceeds estimated at ~$4.4 million after fees and expenses
- Pre-offering cash balance was only $168,474 as of March 31, 2026
- Shares outstanding increase from 40,522,002 to 43,022,002 (6.2% dilution)
- Existing stockholders' net tangible book value goes from ($0.04) to $0.02 per share; new investors face immediate dilution of $1.98 per share
- 90-day lock-up agreements for officers, directors, and 5%+ holders
- Gross proceeds $5.0M vs market cap $328M — a small absolute raise but extreme pricing discount
Financial Impact
6.2% dilution to existing shareholders; offering priced at a 75% discount to market, implying severe capital constraints
Risk Factors
- Further dilution from additional equity raises given tiny cash position
- PRC regulatory risks including CSRC filing requirements and potential HFCAA delisting
- Negative tangible book value and accumulated deficit of ($48.4M)
- Short-term borrowings of $3.4M exceed pre-offering cash
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-080581 |
| Document: 0001213900-26-080581-index-headers.html | 0001213900-26-080581 |
| Document: 0001213900-26-080581-index.html | 0001213900-26-080581 |
| Document: 0001213900-26-080581.txt | 0001213900-26-080581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 13w ago | 424B5 | $1.85 $0.7279 | ▲ +60.65% | ▲ +65.21% | $0.6348 (+65.69%) |
Jul 22, 2026 13w ago | 8-K | $1.85 $0.7279 | ▼ −60.65% | ▼ −65.21% | $0.6348 (−65.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers